Posts

New nano strategy may reduce dose of main HIV remedy in half

The healthy volunteer trial, conducted by the c ollaborative nanomedicine research programme led by Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, and in collaboration with the St Stephen's AIDS Trust at the Chelsea & Westminster Hospital in London, examined the use of nanotechnology to improve the delivery of drugs to HIV patients. The results were from two trials which are the first to use orally dosed nanomedicine to enable HIV therapy optimisation. Manipulation of matter Nanotechnology is the manipulation of matter on an atomic , molecular, and supramolecular scale. Nanomedicine is the application of nanotechnology to the prevention and treatment of disease in the human body. By developing smaller pills that are better for patients and less expensive to manufacture, this evolving discipline has the potential to dramatically change medical science and is already having an impact in a number of clinically used therapies and diagnos...

New TB drug candidates developed from soil bacteria

A brand new therapy for tuberculosis (TB ) is about to be developed utilizing compounds derived from micro organism that stay in soil -- in accordance a world collaboration of researchers, together with the College of Warwick. The analysis partnership -- involving the College of Warwick, and spanning establishments from Australia, Canada and the USA -- has found a compound which may translate into a brand new drug lead for TB. The group checked out soil micro organism compounds, recognized to successfully forestall different micro organism rising round them. Utilizing artificial chemistry , the researchers have been capable of recreate these compounds with structural variations, turning them into stronger chemical analogues. When examined in a containment laboratory, these analogues proved to be efficient killers of Mycobacterium tuberculosis -- the bacterium which causes TB. These chemical compounds goal an enzyme in Mycobacterium tuberculosis referred to as MraY, which catalys...

Cholesterol-processing enzyme protects from debilitating brain lesions

An enzyme that helps break down ldl cholesterol may be a therapeutic goal to stave off neurologic ailments, together with Alzheimer's and a uncommon genetic dysfunction, in accordance with a brand new research printed within the  Journal of Organic Chemistry . Researchers from Case Western Reserve College Faculty of Medication, the Nationwide Institute of Requirements and Expertise, and Karolinska Institute in S weden foun d particular enzyme within the mind might cut back the formation of debilitating mind lesions within the two ailments. A medical trial to check the enzyme's potential as a therapeutic goal is deliberate for later this 12 months. The focused enzyme's major objective is to remove extra ldl cholesterol from the mind. However the researchers hypothesized it might additionally assist take away one other cholesterol-like molecule -- cholestanol. Cholestanol is generally present in very low ranges within the physique, a minimum of 500 instances much less usu...